LabCorp announced that it is launching a new return-to-work service for employers, according to a company news release.
LabCorp said it launched the service to respond to requests from companies developing return-to-work strategies for the summer and fall.
LabCorp Employer Services provides customized return-to-work solutions using LabCorp’s trained medical staff for employee check-in health questionnaires, temperature screens, and COVID-19 test collection at the employer site or offsite. The service gives employers access to LabCorp’s COVID-19 testing solutions including its at-home collection test kit, its fingerstick antibody blood test, and in the fall, flu vaccination services.
LabCorp’s fingerstick, or dried blood spot, IgG antibody test is being provided as a laboratory developed test and uses the EUROIMMUN test, which received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA). LabCorp completed independent validation studies.
